Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection

BACKGROUND Chagas disease, which is caused by the protozoan Trypanosoma cruzi, is endemic to Latin America and mainly affects low-income populations. Chemotherapy is based on two nitrocompounds, but their reduced efficacy encourages the continuous search for alternative drugs. Our group has characterised the trypanocidal effect of naphthoquinones and their derivatives, with naphthoimidazoles derived from β-lapachone (N1, N2 and N3) being the most active in vitro. OBJECTIVES In the present work, the effects of N1, N2 and N3 on acutely infected mice were investigated. METHODS in vivo activity of the compounds was assessed by parasitological, biochemical, histopathological, immunophenotypical, electrocardiographic (ECG) and behavioral analyses. FINDINGS Naphthoimidazoles led to a decrease in parasitaemia (8 dpi) by reducing the number of bloodstream trypomastigotes by 25-50% but not by reducing mortality. N1 protected mice from heart injury (15 dpi) by decreasing inflammation. Bradycardia was also partially reversed after treatment with N1 and N2. Furthermore, the three compounds did not reverse hepatic and renal lesions or promote the improvement of other evaluated parameters. MAIN CONCLUSION N1 showed moderate trypanocidal and promising immunomodulatory activities, and its use in combination with benznidazole and/or anti-arrhythmic drugs as well as the efficacy of its alternative formulations must be investigated in the near future.

Saved in:
Bibliographic Details
Main Authors: Cascabulho,Cynthia M, Meuser-Batista,Marcelo, Moura,Kelly Cristina G de, Pinto,Maria do Carmo, Duque,Thabata Lopes Alberto, Demarque,Kelly C, Guimarães,Ana Carolina Ramos, Manso,Pedro Paulo de Abreu, Pelajo-Machado,Marcelo, Oliveira,Gabriel M, Castro,Solange L De, Menna-Barreto,Rubem FS
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762020000100301
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762020000100301
record_format ojs
spelling oai:scielo:S0074-027620200001003012020-02-11Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infectionCascabulho,Cynthia MMeuser-Batista,MarceloMoura,Kelly Cristina G dePinto,Maria do CarmoDuque,Thabata Lopes AlbertoDemarque,Kelly CGuimarães,Ana Carolina RamosManso,Pedro Paulo de AbreuPelajo-Machado,MarceloOliveira,Gabriel MCastro,Solange L DeMenna-Barreto,Rubem FS Trypanosoma cruzi Chagas disease chemotherapy naphthoimidazoles heart cardiomyopathy BACKGROUND Chagas disease, which is caused by the protozoan Trypanosoma cruzi, is endemic to Latin America and mainly affects low-income populations. Chemotherapy is based on two nitrocompounds, but their reduced efficacy encourages the continuous search for alternative drugs. Our group has characterised the trypanocidal effect of naphthoquinones and their derivatives, with naphthoimidazoles derived from β-lapachone (N1, N2 and N3) being the most active in vitro. OBJECTIVES In the present work, the effects of N1, N2 and N3 on acutely infected mice were investigated. METHODS in vivo activity of the compounds was assessed by parasitological, biochemical, histopathological, immunophenotypical, electrocardiographic (ECG) and behavioral analyses. FINDINGS Naphthoimidazoles led to a decrease in parasitaemia (8 dpi) by reducing the number of bloodstream trypomastigotes by 25-50% but not by reducing mortality. N1 protected mice from heart injury (15 dpi) by decreasing inflammation. Bradycardia was also partially reversed after treatment with N1 and N2. Furthermore, the three compounds did not reverse hepatic and renal lesions or promote the improvement of other evaluated parameters. MAIN CONCLUSION N1 showed moderate trypanocidal and promising immunomodulatory activities, and its use in combination with benznidazole and/or anti-arrhythmic drugs as well as the efficacy of its alternative formulations must be investigated in the near future.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.115 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762020000100301en10.1590/0074-02760190389
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Cascabulho,Cynthia M
Meuser-Batista,Marcelo
Moura,Kelly Cristina G de
Pinto,Maria do Carmo
Duque,Thabata Lopes Alberto
Demarque,Kelly C
Guimarães,Ana Carolina Ramos
Manso,Pedro Paulo de Abreu
Pelajo-Machado,Marcelo
Oliveira,Gabriel M
Castro,Solange L De
Menna-Barreto,Rubem FS
spellingShingle Cascabulho,Cynthia M
Meuser-Batista,Marcelo
Moura,Kelly Cristina G de
Pinto,Maria do Carmo
Duque,Thabata Lopes Alberto
Demarque,Kelly C
Guimarães,Ana Carolina Ramos
Manso,Pedro Paulo de Abreu
Pelajo-Machado,Marcelo
Oliveira,Gabriel M
Castro,Solange L De
Menna-Barreto,Rubem FS
Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
author_facet Cascabulho,Cynthia M
Meuser-Batista,Marcelo
Moura,Kelly Cristina G de
Pinto,Maria do Carmo
Duque,Thabata Lopes Alberto
Demarque,Kelly C
Guimarães,Ana Carolina Ramos
Manso,Pedro Paulo de Abreu
Pelajo-Machado,Marcelo
Oliveira,Gabriel M
Castro,Solange L De
Menna-Barreto,Rubem FS
author_sort Cascabulho,Cynthia M
title Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
title_short Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
title_full Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
title_fullStr Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
title_full_unstemmed Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
title_sort antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute trypanosoma cruzi infection
description BACKGROUND Chagas disease, which is caused by the protozoan Trypanosoma cruzi, is endemic to Latin America and mainly affects low-income populations. Chemotherapy is based on two nitrocompounds, but their reduced efficacy encourages the continuous search for alternative drugs. Our group has characterised the trypanocidal effect of naphthoquinones and their derivatives, with naphthoimidazoles derived from β-lapachone (N1, N2 and N3) being the most active in vitro. OBJECTIVES In the present work, the effects of N1, N2 and N3 on acutely infected mice were investigated. METHODS in vivo activity of the compounds was assessed by parasitological, biochemical, histopathological, immunophenotypical, electrocardiographic (ECG) and behavioral analyses. FINDINGS Naphthoimidazoles led to a decrease in parasitaemia (8 dpi) by reducing the number of bloodstream trypomastigotes by 25-50% but not by reducing mortality. N1 protected mice from heart injury (15 dpi) by decreasing inflammation. Bradycardia was also partially reversed after treatment with N1 and N2. Furthermore, the three compounds did not reverse hepatic and renal lesions or promote the improvement of other evaluated parameters. MAIN CONCLUSION N1 showed moderate trypanocidal and promising immunomodulatory activities, and its use in combination with benznidazole and/or anti-arrhythmic drugs as well as the efficacy of its alternative formulations must be investigated in the near future.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762020000100301
work_keys_str_mv AT cascabulhocynthiam antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT meuserbatistamarcelo antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT mourakellycristinagde antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT pintomariadocarmo antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT duquethabatalopesalberto antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT demarquekellyc antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT guimaraesanacarolinaramos antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT mansopedropaulodeabreu antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT pelajomachadomarcelo antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT oliveiragabrielm antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT castrosolangelde antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
AT mennabarretorubemfs antiparasiticandantiinflammatoryactivitiesofßlapachonederivednaphthoimidazolesinexperimentalacutetrypanosomacruziinfection
_version_ 1756383909315084288